BMRA.OB: Summary for BIOMERICA INC - Yahoo! Canada Finance

MORE ON BMRA.OB

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

BIOMERICA INC (OTC BB:BMRA.OB) Delayed quote data

Last Trade:	0.38 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	0.38
Open:	N/A
Bid:	0.38 x 5000
Ask:	0.42 x 5000
1y Target Est:	N/A

Day's Range:	N/A - N/A
52wk Range:	0.74 - 1.89
Volume:	0
Avg Vol (3m):	4,168.75
Market Cap:	2.53M
P/E (ttm):	2.12
EPS (ttm):	0.18
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add BMRA.OB to Portfolio

Download Data

HEADLINES

•	BIOMERICA INC Financials
	EDGAR Online Financials (Sat, Jan 23)

•	Biomerica Announces Second Quarter Financial Results
	Marketwire (Wed, Jan 20)

•	BIOMERICA INC Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Tue, Jan 19)

•	Biomerica Purchases the Technology, Know-How and Manufacturing Rights for 7 New Gastrointestinal Enteric Tests
	Marketwire (Tue, Jan 12)

•	Biomerica Announces Plans for New Headquarters in Irvine, California
	Marketwire (Wed, Oct 28)

•	Biomerica Announces First Quarter Financial Results
	Marketwire (Fri, Oct 16)

•	BIOMERICA INC Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, Oct 16)

•	Biomerica Announces Year End Results
	Marketwire (Tue, Sep 1)

•	BIOMERICA INC Files SEC form 10-K, Annual Report
	EDGAR Online (Mon, Aug 31)

•	Biomerica Purchases the Assets, Technology and Rights for New Celiac Disease Tests
	Marketwire (Tue, Apr 28)

More Headlines for BMRA.OB...

ANALYST

EPS Est (next year) (Dec-69) :	N/A
EPS Est (in 2 years) (Dec-69) :	N/A
Avg Rec (current)*:	N/A
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Biomerica, Inc. develops, manufactures, and markets medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions.

Full Company Profile

Add to Portfolio

Email to a Friend

•

	Sign In [New User? Sign Up]	Finance Home \|Help

Biomerica Inc. (BMRA.OB)